Skip to main content

Advertisement

SpringerLink
Log in

Autoimmunity in Hyper-IgM Syndrome

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Introduction

Immunodeficiency with hyper-IgM (HIGM) results from genetic defects in the CD40–CD40 ligand (CD40L) pathway or in the enzymes required for immunoglobulin class switch recombination and somatic hypermutation. HIGM can thus be associated with an impairment of both B-cell and T-cell activation.

Results and discussions

There are seven main subtypes of HIGM and the most frequent is X-linked HIGM, resulting from CD40L mutations. In addition to the susceptibility to recurrent and opportunistic infections, these patients are prone to autoimmune manifestations, especially hematologic abnormalities, arthritis, and inflammatory bowel disease. Furthermore, organ-specific autoantibodies are commonly found in HIGM patients.

Conclusions

The mechanisms by which HIGM associates to autoimmunity are not completely elucidated but a defective development of regulatory T cells, the presence of IgM autoantibodies and an impaired peripheral B-cell tolerance checkpoint have been implicated. This article reviews the main subtypes of HIGM syndrome, the clinical autoimmune manifestations found in these patients, and the possible mechanisms that would explain this association.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120:399–405.

    Article  PubMed  CAS  Google Scholar 

  2. Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005;203:48–66.

    Article  PubMed  CAS  Google Scholar 

  3. Hervé M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med 2007;204:1583–93.

    Article  PubMed  CAS  Google Scholar 

  4. Hess S, Engelmann H. A novel function of CD40: induction of cell death in transformed cells. J Exp Med 1996;183:159–67.

    Article  PubMed  CAS  Google Scholar 

  5. Etzioni A, Ochs HD. The hyper IgM syndrome—an evolving story. Pediatr Res 2004;56:519–25.

    Article  PubMed  CAS  Google Scholar 

  6. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997;131:47–54.

    Article  PubMed  CAS  Google Scholar 

  7. Facchetti F, Appiani C, Salvi L, Levy J, Notarangelo LD. Immunohistologic analysis of ineffective CD40–CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 1995;154:6624–33.

    PubMed  CAS  Google Scholar 

  8. Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998;92:2421–34.

    PubMed  CAS  Google Scholar 

  9. Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol 2006;117:855–64.

    Article  PubMed  CAS  Google Scholar 

  10. van Kooten C, Banchereau J. CD40–CD40 ligand. J Leukoc Biol 2000;67:2–17.

    PubMed  Google Scholar 

  11. Van Hoeyveld E, Zhang PX, De Boeck K, Fuleihan R, Bossuyt X. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Immunology 2007;120:497–501.

    Article  PubMed  CAS  Google Scholar 

  12. Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003;27:185–202.

    Article  PubMed  CAS  Google Scholar 

  13. Durandy A, Peron S, Fischer A. Hyper-IgM syndromes. Curr Opin Rheumatol 2006;18:369–76.

    Article  PubMed  CAS  Google Scholar 

  14. Durandy A, Revy P, Imai K, Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 2005;203:67–79.

    Article  PubMed  CAS  Google Scholar 

  15. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000;102:565–75.

    Article  PubMed  CAS  Google Scholar 

  16. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001;2:223–8.

    Article  PubMed  CAS  Google Scholar 

  17. Gulino AV, Notarangelo LD. Hyper IgM syndromes. Curr Opin Rheumatol 2003;15:422–9.

    Article  PubMed  CAS  Google Scholar 

  18. Lacroix-Desmazes S, Resnick I, Stahl D, Mouthon L, Espanol T, Levy J, et al. Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome. J Immunol 1999;162:5601–8.

    PubMed  CAS  Google Scholar 

  19. Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis 1998;178:318–24.

    PubMed  CAS  Google Scholar 

  20. Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003;82:373–84.

    Article  CAS  Google Scholar 

  21. Webster EA, Khakoo AY, Mackus WJ, Karpusas M, Thomas DW, Davidson A, et al. An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome). Arthritis Rheum 1999;42:1291–6.

    Article  PubMed  CAS  Google Scholar 

  22. Melegari A, Mascia MT, Sandri G, Carbonieri A. Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome. Ann N Y Acad Sci 2007;1109:106–8.

    Article  PubMed  Google Scholar 

  23. Quartier P, Bustamante J, Sanal O, Plebani A, Debré M, Deville A, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 2004;110:22–9. Erratum in: Clin Immunol. 113:220, 2004.

    Article  PubMed  CAS  Google Scholar 

  24. Orange JS, Levy O, Geha RS. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005;203:21–37.

    Article  PubMed  CAS  Google Scholar 

  25. Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, et al. Increased T cell autoreactivity in the absence of CD40–CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol 2001;166:353–60.

    PubMed  CAS  Google Scholar 

  26. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996;18(87):319–29.

    Article  Google Scholar 

  27. Datta SK, Kalled SL. CD40–CD40 ligand interaction in autoimmune disease. Arthritis Rheum 1997;40:1735–45.

    Article  PubMed  CAS  Google Scholar 

  28. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Rheumatology Unit, Pediatrics Department, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar 500 IMT Bldg. II 3rd floor, São Paulo, Sao Paulo, 054030-000, Brazil

    Adriana A. Jesus

  2. Laboratory of Medical Investigation Unit 56 (LIM-56), Dermatology Department, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 500 IMT Bldg. II 3rd floor, São Paulo, Sao Paulo, 054030-000, Brazil

    Alberto J. S. Duarte & João B. Oliveira

  3. Research Institute, Hospital do Coração, São Paulo, Sao Paulo, Brazil

    João B. Oliveira

Authors
  1. Adriana A. Jesus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alberto J. S. Duarte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. João B. Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to João B. Oliveira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jesus, A.A., Duarte, A.J.S. & Oliveira, J.B. Autoimmunity in Hyper-IgM Syndrome. J Clin Immunol 28 (Suppl 1), 62–66 (2008). https://doi.org/10.1007/s10875-008-9171-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-008-9171-x

Keywords

Search

Navigation